BACKGROUND Typically occurring on the external genitalia, anogenital warts (AGWs) are
benign epithelial skin lesions caused by human papillomavirus infection. AGWs are usually …

… A few previous economic analyses of genital wart therapy … An economic evaluation should
preferably reflect real clinical … evaluation of this preparation in adults with genital warts …

… to genital warts. These estimates have been used in a previously published economic
evaluation of HPV … have also been used in economic evaluations of HPV vaccination are broadly …

… for penile warts and the 0.15% cream formulation is easy to apply for patients with vulvar and
anal warts. A very … Randomised controlled trial and economic evaluation of patient applied …

… In search of estimates of per-patient costs, we also investigated the economic evaluations
of various health technologies for prevention or treatment of EGW. Amongst the plethora of …

… Genital warts are caused by HPV types 6 and 11, which are responsible for more than 90%
of cases. In Italy, it has been estimated that the prevalence of genital warts in … of genital warts, …

… about the value of vaccination against genital warts,1 … of care for use in further economic
evaluations of HPV vaccination. … Future economic evaluations of HPV vaccination will be able to …

… The potential savings to the health service from GW prevention by the quadrivalent vaccine
were considered in the economic evaluation of vaccine choice in 2007 in the UK.8 At that …

… anogenital warts. ConclusionsRoutine vaccination of 12 year old schoolgirls combined with
an initial catch-up campaign up to age 18 is likely to be cost effective in the UK. The results …

… cancer (CC), and genital warts. However, few have been done in Africa and none in Swaziland.
Cost analysis is critical in providing useful information for economic evaluations to guide …